Results 41 to 50 of about 19,123,678 (263)
Singapore Medical JournalIntroduction: Achieving low-density lipoprotein cholesterol (LDL-C) levels is key to preventing atherosclerotic cardiovascular events. However, many high-risk cardiovascular patients still experience poor LDL-C goal attainment and receive suboptimal ...
Ying Hui Mak +9 more
doaj +1 more source
Sertraline Treatment Can Mimic Niemann‐Pick Type C Biomarker Profile: A Diagnostic Pitfall
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Background Oxysterols (cholestane‐3β,5α,6β‐triol and 7‐ketocholesterol) and N‐palmitoyl‐O‐phosphocholineserine (PPCS) are sensitive biomarkers for Niemann‐Pick disease type C (NPC) screening. However, false‐positive results occur, with a biomarker profile suggestive of NPC despite the absence of pathogenic variants in genes involved in NPC or ...
Maria Makrygianni +19 more
wiley +1 more source
Journal of Applied Hematology, 2022 CONTEXT: Low-density lipoprotein cholesterol (LDL-C) is the classical target in cardiovascular (CV) disease management and is usually estimated by Friedewald's formula. However, this formula may over- or underestimate LDL-C levels.
Zuhier Ahmed Awan +1 more
doaj +1 more source
LDL-c and NAFLD in the non-obese population
, 2016 data about NAFLD within the normal LDL-c range in non-obese subjects in cross-sectional and longitudinal population from 2010 to ...
Li-Ren Wang (3349052) +19 more
core +1 more source
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective To characterize the demographic, clinical, and laboratory features of the Chinese patients of genetic Creutzfeldt‐Jakob disease with T188K variant (T188K‐gCJD), the most common subtype of genetic prion diseases (gPrDs) in China. Methods In this nationwide retrospective study, data from 98 genetically confirmed T188K‐gCJD patients ...
Chun‐Jie Li +11 more
wiley +1 more source
, 2011 Copyright information:Taken from "Optimal Lipid Modification: The Rationale for Combination Therapy"Vascular Health and Risk Management 2005;1(4):317-331.Published online Jan 2005PMCID:PMC1993967.© 2005 Dove Medical Press Limited.
Patricia A Howard (79689) +2 more
core +1 more source
Is the 2020 Sampson equation the best formula for LDL-C estimation?
, 2021 More than 4 million deaths in Europe are caused by cardiovascular disease (CVD) each year. Low-density lipoprotein-cholesterol (LDLC) has been demonstrated to be one of the major eterminants of atherogenesis and CVD burden, resulting the most important ...
Piani F +3 more
core +1 more source
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Background Ischemic stroke, a major cause of mortality and long‐term disability, results from the abrupt cessation of cerebral blood flow due to vascular occlusion or rupture. Icosapent Ethyl (EPA‐EE), approved for hypertriglyceridemia, has anti‐inflammatory and antithrombotic properties that may lessen ischemic damage.
Mitra Mahmoudi Meymand +5 more
wiley +1 more source
Revista de Ciências da Saúde Nova Esperança, 2005 Esta pesquisa foi realizada com o objetivo de avaliar os níveis sanguíneos de colesterol total, LDL-C, HDL-C e triglicérides. A população estudada foi selecionada a partir de uma amostragem aleatória simples, constituiu-se de 220 pacientes, sendo 102 do ...
Carolina Uchôa Guerra Barbosa +2 more
doaj +1 more source
Non-invasive skin cholesterol testing: a potential proxy for LDL-C and apoB serum measurements
Lipids in Health and Disease, 2021 Background Lipid management is the first line of treatment for decreasing the incidence of cardiovascular events in patients with coronary heart disease (CHD), and a variety of indicators are used to evaluate lipid management.
Jiacheng Lai +7 more
doaj +1 more source